How Does Hormone Replacement Therapy (HRT) Benefit Women After Surgical Menopause?
When we go through surgical menopause — usually because both ovaries are removed — our body will experience a sudden, profound change. Unlike natural menopause, where hormone levels drift down over months or years, surgical menopause cuts off the body’s primary sources of oestrogen, progesterone and testosterone almost overnight. For many of us, that shift brings immediate and often severe symptoms: hot flushes, sleep disruption, mood swings, loss of libido, brain fog and more. But the effects are much deeper than symptoms alone, impacting on our long-term heart, brain and bone health.
This is where hormone replacement therapy (HRT) becomes important. Not because it’s optional or cosmetic, but because it replaces what the body has literally lost. Increasingly, research now suggests that it does so without increasing long-term harm. A new nationwide study published in The BMJ — tracking nearly a million women over more than a decade — found that menopausal hormone therapy (HRT) was not associated with increased mortality and even showed survival benefits for women after non-cancer ovary removal in mid-life.
That’s an important shift from decades of fear and confusion about hormone therapy following the publication of the WHI Study in 2002, and for those of us whose ovaries were removed before their natural menopause would have occurred, it matters greatly.
Let’s break down what we know now about how HRT benefits women after surgical menopause — what it relieves, what it protects, and what emerging evidence tells us.
HRT is Hormone Replacement, Not Optional Hormone “Suppression”
After surgical menopause, the ovaries stop producing hormones the body expected to have for another decade or more. In women under the natural age of menopause (about 51 in the UK), those hormones — especially oestrogen — play roles in:
regulating body temperature
protecting bone density
maintaining healthy cholesterol and blood vessel function
influencing mood and cognition
supporting sexual function
Replacing those hormones isn’t about “treating symptoms” the way painkillers treat a headache — it’s about replacing what is suddenly missing. In this context, clinicians and guideline bodies in obstetrics and gynaecology generally recommend HRT for women undergoing early surgical menopause, unless there’s a specific medical reason not to.
That distinction — replacement rather than elective therapy — is crucial when we think about both short-term recovery and long-term health.
Easing the Immediate, Often Intense Symptoms
Women often describe surgical menopause as “falling off a cliff” — overnight hot flushes, night sweats, sleep problems, mood shifts and low libido can come on hard. HRT is very effective at relieving these symptoms because it supplies the hormones the body no longer makes.
While there’s variability in individual experiences and formulations, the practical reality for many women is a noticeable improvement in quality of life once HRT is started: cooler nights, more stable mood, better sleep and improved sexual wellbeing. That matters in its own right, but it also matters because persistent symptoms can spill over into anxiety, depression and other health impacts.
Protecting Your Bone Health
Oestrogen is a key regulator of bone metabolism. When levels plummet after surgical menopause, bones lose density quickly. Left untreated, that accelerates the risk of osteopenia, osteoporosis and fracture later in life.
Here’s the point: HRT slows that loss and helps preserve bone density. It’s not a temporary fix — it’s about lowering future fracture risk by giving the skeleton a hormonal environment closer to what it would have had before surgery.
Support For Your Heart Health
Historically, the role of HRT and heart health has been controversial. But in the recent Danish study, 800,000 women in Denmark were followed for a median of more than 14 years and researchers found no increased risk of death from any cause in women using menopausal hormone therapy, even after long-term use.
Crucially for women in surgical menopause, those in the study who had undergone bilateral ovary removal for benign reasons between ages 45–54 ,and used hormone therapy showed a significant survival benefit: roughly a 27–34% lower risk of death, compared with similar women who did not use HRT.
That finding doesn’t prove cause and effect – it’s important to note that observational research can’t do that. But it does challenge one of the old fears about long-term hormone use and mortality, and suggests that in women with early oestrogen loss, replacing hormones may have protective value.
What About Our Brain Health?
Oestrogen has roles in brain function; influencing synaptic activity, blood flow and metabolism. Although we don’t have a definitive prevention trial in surgical menopause, several observational and mechanistic studies point to early hormone loss being linked to cognitive complaints and possibly long-term risk. Restoring physiological hormone levels during mid-life could plausibly support cognitive function, reduce subjective “brain fog”, and contribute to long-term brain resilience.
The Gap Between Evidence and Practice
Strikingly, despite clear evidence that HRT can improve quality of life and support long-term health after surgical menopause, many women are still not offered it. Surveys of real-world care show that a majority of women aren’t told about HRT before surgery, and 95% of women leave hospital without being started on HRT. We know from women’s experiences that primary care clinicians often feel under-confident managing it for women in a state of hormone deficiency.
That’s a problem of care delivery, not a problem with the therapy itself — and it’s a gap that we deserve to see closed.
Individualised Care Matters
We know that no medical treatment is one-size-fits-all. For women with a history of hormone-sensitive cancers or certain clotting disorders, the balance of risks and benefits needs careful, specialist discussion. But for women undergoing surgical menopause without those contraindications, research supports HRT as a beneficial, well-tolerated option that replaces what was lost, improves symptoms and aligns with current evidence on mortality and long-term health.
HRT Is More Than Just Stopping Hot Flushes
For women who experience surgical menopause, HRT is more than a way to ease hot flushes and sleep problems. It restores hormones that the body no longer produces, supports bone and cardiovascular health, and — in large observational data — is not linked to increased risk of death, with potential survival benefits when used after non-cancer ovary removal.
That doesn’t make it right for every single woman in every circumstance — but it should make it part of the conversation for anyone facing surgical menopause.
